Real-time enrollment status for this hidradenitis suppurativa clinical trial
Current Status
Recruiting
Checked: October 22, 2026 at 1:53 AM UTC
| NCT Number | NCT07855276 |
| Recruiting Status | Recruiting |
| Condition | Hidradenitis Suppurativa |
| Phase | PHASE1 |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | October 16, 2026 (6 days ago) |
As of October 22, 2026: Clinical trial NCT07855276 is currently recruiting participants. This phase1 study for hidradenitis suppurativa is actively seeking new participants at 1 location across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07855276 is actively recruiting participants as of October 22, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07855276 was last updated 6 days ago (October 16, 2026). HelloStudys verifies this status automatically.